Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026)
Revvity (RVTY) posted Liabilities and Shareholders Equity of $12.0 billion for Q2 2026, down 1.41% quarter-over-quarter from $12.2 billion in Q4 2025, and down 2.95% year-on-year from $12.4 billion in Q2 2025.
Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $12.0 billion the latest figure, recorded in Q2 2026.
- Liabilities and Shareholders Equity for Q2 2026 came in at $12.0 billion, down 2.95% year-over-year; the trailing twelve-month figure through Apr 2026 was $48.7 billion (down 4.48% YoY), and the FY2025 annual result was $12.2 billion, down 1.81% from the prior year.
- Liabilities and Shareholders Equity was $12.0 billion for Q2 2026 at Revvity, down from $12.2 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $15.0 billion in Q1 2022 and troughed at $12.0 billion in Q2 2026.
- Average Liabilities and Shareholders Equity over 5 years is $13.4 billion, with a median of $13.4 billion recorded in 2024.
- Year-over-year, Liabilities and Shareholders Equity surged 88.44% in 2022 and decreased 8.64% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $13.8 billion in 2022, then slipped by 1.87% to $13.6 billion in 2023, then slipped by 8.64% to $12.4 billion in 2024, then fell by 1.81% to $12.2 billion in 2025, then decreased by 1.41% to $12.0 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $12.0 billion in Q2 2026, $12.2 billion in Q4 2025, and $12.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 2.61 Bn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 13.07 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Revvity | 12.62 Bn | 11.76 Bn | 387.66 Mn | 12.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 12.00 Bn |
| Dec 28, 2025 | 12.17 Bn |
| Sep 28, 2025 | 12.14 Bn |
| Jun 29, 2025 | 12.36 Bn |
| Mar 30, 2025 | 12.36 Bn |
| Dec 29, 2024 | 12.39 Bn |
| Sep 29, 2024 | 12.77 Bn |
| Jun 30, 2024 | 13.42 Bn |
| Mar 31, 2024 | 13.43 Bn |
| Dec 31, 2023 | 13.56 Bn |
| Oct 1, 2023 | 13.42 Bn |
| Jul 2, 2023 | 14.22 Bn |
| Apr 2, 2023 | 14.64 Bn |
| Jan 1, 2023 | 14.13 Bn |
| Oct 2, 2022 | 13.82 Bn |
| Jul 3, 2022 | 14.19 Bn |
| Apr 3, 2022 | 14.85 Bn |
| Jan 2, 2022 | 15.00 Bn |
| Oct 3, 2021 | 14.90 Bn |
| Jul 4, 2021 | 8.74 Bn |